Skip to main content
. 2019 Aug 8;6:114. doi: 10.3389/fcvm.2019.00114

Table 2.

An overview of the use of blood products during support with extracorporeal membrane oxygenation (ECMO) for all patients (n = 33).

Amount, mL RBC, n (%) FFP, n (%) Platelets, n (%)
None 3 (9%) 14 (43%) 14 (43%)
1–1,500 14 (43%) 13 (39%) 8 (24%)
1,500–3,000 9 (27%) 2 (6%) 7 (21%)
3,000–4,500 2 (6%) 1 (3%) 2 (6%)
>4,500 5 (15%) 3 (9%) 2 (6%)

ECMO, Extracorporeal membrane oxygenation; RBC, Red blood cells; FFP, Fresh-frozen plasma; mL, milliliter.